JONES RYAN ALEXANDER (Chief Financial Officer) received a stock award from KYVERNA THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 4/15/2025ACC: 0000950170-25-054344
Officer· Chief Financial Officer
Since Feb 2024
+86K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
86K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+12K
Price / share
—
Trade value
—
% of position
27.3%
4/11/2025
43.95K→55.95K
Total
Net shares
+12K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/11/2025 | A · Award | +12K | — | — | 27.3% | 43.95K | 55.95K |
| Total | +12K | $0.00 | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
74K shares
Shares
+74K
Strike price
2.06
Held after
74K
Exercisable
—
4/11/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock74K shares | 4/11/2024 | A · Award | +74K | 2.06 | — | 74K |